REACH is a European Community Regulation on chemicals and their safe use (EC 1907/2006). It deals with the Registration, Evaluation, Authorization and Restriction of Chemical substances. The law entered into force on June 1, 2007.
All manufacturers and importers of chemicals must identify and manage risks linked to the substances they manufacture and market.
For substances produced or imported in quantities of one tonne or more per year per company, manufacturers and importers need to demonstrate that they have appropriately identified and managed the risks by means of a registration dossier, which must be submitted to the European Chemicals Agency (ECHA).
Melexis has evaluated our manufactured products and determined that we do not import nor produce articles containing substances that are released under normal conditions of use. Therefore we are not obliged to register the substances of our articles. As we are not potential registrants, we will not pre-register either.
As a consequence we take this opportunity to inform you that Melexis will not pre-register, nor register our substances in articles, as mentioned in art. 28 and art. 7 §1 of the REACH directive.
Melexis recognizes that companies not compliant with REACH will be unable to access markets within the European Union (EU). Therefore, we are notifying our suppliers of chemicals and other substances that are affected by this REACH directive of their (pre-) registration obligation and their obligation to take the necessary actions to be compliant.
The candidate list of Substances of Very High Concern (SVHC) that are subject to authorization was released by ECHA. Additional substances are regularly added to this list and published by the ECHA (Candidate List of SVHC).
Melexis reviewed the bill of materials of its articles to identify those parts containing SVHC
After each update of the candidate list of SVHC Melexis is reviewing the bill of materials of its articles again to identify those parts containing SVHC
- Melexis will inform our customer in cases where it uses substances containing above 0.1% of SVHC in weight by weight
Download Melexis REACH Statement (PDF - 86 KB)